Filter
1352
Text search:
sti
Featured
109
492
Language
Document type
975
154
69
53
37
20
18
6
5
4
3
2
1
Countries / Regions
86
80
56
52
47
42
39
39
39
28
28
24
23
23
22
21
20
18
17
16
14
14
14
13
13
11
10
9
8
8
8
7
7
6
6
5
5
5
5
5
4
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
773
107
89
45
35
33
1
Toolboxes
282
50
28
17
15
14
11
11
8
8
8
7
7
6
6
5
3
2
1
1
1
1
Evaluation report
September 2014
Сборник индикаторов для мониторинга и оценки национальных программ борьбы с туберкулезом
recommended
Борьба с туберкулезом представляет собой одну из ведущих областей, в которых ведется регулярный сбор информации, которая измеряет самые критические показатели вы
...
Case Study on Improving HIV Testing and Services for Children Orphaned or made Vulnerable by HIV (OVC)
Consolidated Guidelines
Geneva, 2016
The End TB Strategy
Practical Guidance for collaborative interventions
The aim of the operational framework is to ensure 1) accurate collection, handling, shipment and storage of specimens collected in countries implementing HIV drug resistance surveillance; and 2) the availability of quality-assured HIV genotyping laboratory services producing comparable and reliable
...
WHO recommends that pre-exposure prophylaxis (PrEP) be offered as an additional prevention choice for HIV-negative individuals at substantial risk of HIV infection as part of combination prevention approaches.
HIV drug resistance has been rarely reported among PrEP users who tested HIV positive i
...
Editorial
Rev Panam Salud Publica 40(6), 2016
This implementation tool describes the recommended approaches for routine monitoring of toxicity integrated with the national monitoring and evaluation system and targeted approaches to monitoring toxicity to enable enhanced monitoring and reporting of treatment-limiting toxicity to support country
...
The project will support preventive actions, traditional medicine and the coordination and
implementation capacities of the national framework for HIV/AIDS control.
Operational Guideline
Technical Brief
July 2017
Pregnancy often results in exclusion from clinical trials of antiretroviral (ARV) drugs, resulting in limited data on pharmacokinetics (PK), drug safety, and the efficacy of new ARV drugs in pregnancy and lactation. However, pregnancy, lactation, or the potential for pregnancy should not preclude th
...